 |
PDBsum entry 8fnh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Ligand/metal interactions
|
PDB id
|
|
|
|
8fnh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
2 instances of ligand highlighted
|
 |
DLU
|
|
|
Ligand
-
(4r,12as)-N-(2,4-Difluorobenzyl)-7-Hydroxy-4-Methyl-6, 8- Dioxo-3,4,6,8,12,12a-Hexahydro-2h- Pyrido[1',2':4, 5]pyrazino[2,1-B][1,3]oxazine-9-Carboxamide
[Dolutegravir]
Formula: C20H19F2N3O5
|
|
|
|
|
Use mouse to move/zoom
|
|
3D Viewers:
|
|
|

|
|

|
|
|
|

LIGPLOT of interactions involving ligand DLU
|
|
|
|

DLU 304(A)
|

(also representing equivalent ligand
DLU 304(G)
)
|
|
|
');
}
//
// Otherwise, show static image
//
else
{
//
// Show static image
//
document.getElementById('gldiv').innerHTML
= ' ';
//
// Remove 3Dmol icon and comment
//
if (document.getElementById('3dicon'))
{
document.getElementById('3dicon').innerHTML = '';
}
if (document.getElementById('use_mouse'))
{
document.getElementById('use_mouse').innerHTML = '';
}
}
 |